Vascular endothelial growth factor- and thrombin-induced termination factor, Down syndrome critical region-1, attenuates endothelial cell proliferation and angiogenesis.
Minami
Takashi
T
The Research Center for Advanced Science and Technology, the University of Tokyo, Tokyo 153-8904, Japan. minami@med.rcast.u-tokyo.ac.jp
Horiuchi
Keiko
K
Miura
Mai
M
Abid
Md Ruhul
MR
Takabe
Wakako
W
Noguchi
Noriko
N
Kohro
Takahide
T
Ge
Xijin
X
Aburatani
Hiroyuki
H
Hamakubo
Takao
T
Kodama
Tatsuhiko
T
Aird
William C
WC
D000818:Animals; D002455:Cell Division / Q000502:physiology; D002891:Chromosomes, Human, Pair 21; D004268:DNA-Binding Proteins; D004314:Down Syndrome / Q000378:metabolism; D042783:Endothelial Cells / Q000378:metabolism; D005091:Exons; D006801:Humans; D047908:Intracellular Signaling Peptides and Proteins; D051379:Mice; D009124:Muscle Proteins / Q000235:genetics / Q000378:metabolism*; D009389:Neovascularization, Pathologic / Q000378:metabolism*; D011401:Promoter Regions, Genetic; D020033:Protein Isoforms; D012333:RNA, Messenger / Q000378:metabolism; D013917:Thrombin / Q000378:metabolism*; D042461:Vascular Endothelial Growth Factor A / Q000378:metabolism*
D004268:DNA-Binding Proteins; D047908:Intracellular Signaling Peptides and Proteins; D009124:Muscle Proteins; D020033:Protein Isoforms; C108612:RCAN1 protein, human; D012333:RNA, Messenger; D042461:Vascular Endothelial Growth Factor A; D013917:Thrombin